SARS-CoV-2, long COVID, prion disease and neurodegeneration
Y Zhao, VR Jaber, WJ Lukiw - Frontiers in Neuroscience, 2022 - frontiersin.org
On the last day of the year 2019 a novel Betacoronavirus (2019-nCov), now known as
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and causing the highly …
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and causing the highly …
SARS-CoV-2 invasion and pathological links to prion disease
WJ Lukiw, VR Jaber, AI Pogue, Y Zhao - Biomolecules, 2022 - mdpi.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of the
COVID-19 disease, is a highly infectious and transmissible viral pathogen that continues to …
COVID-19 disease, is a highly infectious and transmissible viral pathogen that continues to …
COVID-19, neuropathology, and aging: SARS-CoV-2 neurological infection, mechanism, and associated complications
The spectrum of health complications instigated by coronavirus disease 2019 (COVID-19,
caused by the novel severe acute respiratory syndrome coronavirus 2 or SARS-CoV-2) …
caused by the novel severe acute respiratory syndrome coronavirus 2 or SARS-CoV-2) …
Does SARS-CoV-2 infection cause chronic neurological complications?
The current pandemic caused by severe acute respiratory syndrome coronavirus (SARS-
CoV)-2 has created an unparalleled health crisis. Besides the acute respiratory infection …
CoV)-2 has created an unparalleled health crisis. Besides the acute respiratory infection …
Potential prion involvement in long COVID-19 neuropathology, including behavior
GB Stefano, P Büttiker, S Weissenberger… - Cellular and Molecular …, 2023 - Springer
Prion'is a term used to describe a protein infectious particle responsible for several
neurodegenerative diseases in mammals, eg, Creutzfeldt-Jakob disease. The novelty is that …
neurodegenerative diseases in mammals, eg, Creutzfeldt-Jakob disease. The novelty is that …
Neuropsychiatric and neurodegenerative aspects of acute and long COVID
AF Almulla, HK Al-Hakeim - Frontiers in Molecular Neuroscience, 2023 - frontiersin.org
The escalating prevalence of central nervous system (CNS) symptoms during acute stage
and 3–6 months after coronavirus disease (COVID-19), termed “Long COVID disease,” is a …
and 3–6 months after coronavirus disease (COVID-19), termed “Long COVID disease,” is a …
Short and long-term sequelae within the central nervous system due to COVID-19
LA Méndez-García, JD Carrillo-Ruiz… - Frontiers in Cellular …, 2023 - frontiersin.org
COVID-19 is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
and has affected an estimated 664 million people with over 6.5 million deaths (Cumulative …
and has affected an estimated 664 million people with over 6.5 million deaths (Cumulative …
Pathophysiological clues to how the emergent SARS-CoV-2 can potentially increase the susceptibility to neurodegeneration
Along with emergence of the novel severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) in late 2019, a myriad of neurologic symptoms, associated with structural brain …
CoV-2) in late 2019, a myriad of neurologic symptoms, associated with structural brain …
COVID-19, the brain, and the future: is infection by the novel Coronavirus a harbinger of neurodegeneration?
A Onaolapo, O Onaolapo - CNS & Neurological Disorders …, 2022 - ingentaconnect.com
The possible impact of viral infections on the development or pathogenesis of
neurodegenerative disorders remains largely unknown. However, there have been reports …
neurodegenerative disorders remains largely unknown. However, there have been reports …
A peek into Pandora's box: COVID-19 and neurodegeneration
A Chandra, A Johri - Brain Sciences, 2022 - mdpi.com
Ever since it was first reported in Wuhan, China, the coronavirus-induced disease of 2019
(COVID-19) has become an enigma of sorts with ever expanding reports of direct and …
(COVID-19) has become an enigma of sorts with ever expanding reports of direct and …